A Pilot Study of Renal Hypothermia During Partial Nephrectomy
1 other identifier
interventional
13
1 country
1
Brief Summary
Renal hypothermia may preserve renal function in patients who require partial nephrectomy. In preparation for a definitive randomized controlled trial this pilot study will assess feasibility and variance data to be used for sample size estimation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started Jun 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 24, 2009
CompletedFirst Posted
Study publicly available on registry
April 27, 2009
CompletedStudy Start
First participant enrolled
June 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2011
CompletedJune 9, 2011
June 1, 2011
1.9 years
April 24, 2009
June 8, 2011
Conditions
Outcome Measures
Primary Outcomes (1)
measures of renal function uCrCl be performed for estimation of renal function
3 months
Secondary Outcomes (1)
Post-operative complication
3 months
Study Arms (2)
Normothermia
NO INTERVENTIONAfter arterial clamping, no ice slush will be used
Hypothermia
EXPERIMENTALAfter arterial clamping, the kidney will be surrounded in ice slush for 10 minutes
Interventions
Eligibility Criteria
You may qualify if:
- Patients presenting with a renal mass deemed amenable to an open partial nephrectomy regardless of stage or histology.
- Bilateral renal function on radiographic imaging.
- Willing to consent to randomization.
- Willing to comply with study protocol.
You may not qualify if:
- Anatomically or functionally solitary kidney
- Multiple renal tumours
- Bilateral renal tumours
- Life expectancy \< 3 months as deemed by treating physician
- Age less than 18 years old
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic
Rochester, Minnesota, 55901, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 24, 2009
First Posted
April 27, 2009
Study Start
June 1, 2009
Primary Completion
May 1, 2011
Study Completion
May 1, 2011
Last Updated
June 9, 2011
Record last verified: 2011-06